Time to diagnosis for a rare disease: managing medical uncertainty. A qualitative study.
Diagnosis delay
Interpretive phenomenological analysis
Myositis
Primary immune deficiency
Primary immunodeficiencies
Qualitative
Rare diseases
Uncertainty
Uncertainty management theory
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
14 Aug 2024
14 Aug 2024
Historique:
received:
02
03
2024
accepted:
08
08
2024
medline:
15
8
2024
pubmed:
15
8
2024
entrez:
14
8
2024
Statut:
epublish
Résumé
People with a rare disease commonly experience long delays from the onset of symptoms to diagnosis. Rare diseases are challenging to diagnose because they are clinically heterogeneous, and many present with non-specific symptoms common to many diseases. We aimed to explore the experiences of people with myositis, primary immunodeficiency (PID), and sarcoidosis from symptom onset to diagnosis to identify factors that might impact receipt of a timely diagnosis. This was a qualitative study using semi-structured interviews. Our approach was informed by Interpretive Phenomenological Analysis (IPA). We applied the lens of uncertainty management theory to tease out how patients experience, assess, manage and cope with puzzling and complex health-related issues while seeking a diagnosis in the cases of rare diseases. We conducted interviews with 26 people with a rare disease. Ten participants had been diagnosed with a form of myositis, 8 with a primary immunodeficiency, and 8 with sarcoidosis. Time to diagnosis ranged from 6 months to 12 years (myositis), immediate to over 20 years (PID), and 6 months to 15 years (sarcoidosis). We identified four themes that described the experiences of participants with a rare disease as they sought a diagnosis for their condition: (1) normalising and/or misattributing symptoms; (2) particularising by clinicians; (3) asserting patients' self-knowledge; and (4) working together through the diagnosable moment. Managing medical uncertainty in the time before diagnosis of a rare disease can be complicated by patients discounting their own symptoms and/or clinicians discounting the scale and impact of those symptoms. Persistence on the part of both clinician and patient is necessary to reach a diagnosis of a rare disease. Strategies such as recognising pattern failure and accommodating self-labelling are key to diagnosis.
Sections du résumé
BACKGROUND
BACKGROUND
People with a rare disease commonly experience long delays from the onset of symptoms to diagnosis. Rare diseases are challenging to diagnose because they are clinically heterogeneous, and many present with non-specific symptoms common to many diseases. We aimed to explore the experiences of people with myositis, primary immunodeficiency (PID), and sarcoidosis from symptom onset to diagnosis to identify factors that might impact receipt of a timely diagnosis.
METHODS
METHODS
This was a qualitative study using semi-structured interviews. Our approach was informed by Interpretive Phenomenological Analysis (IPA). We applied the lens of uncertainty management theory to tease out how patients experience, assess, manage and cope with puzzling and complex health-related issues while seeking a diagnosis in the cases of rare diseases.
RESULTS
RESULTS
We conducted interviews with 26 people with a rare disease. Ten participants had been diagnosed with a form of myositis, 8 with a primary immunodeficiency, and 8 with sarcoidosis. Time to diagnosis ranged from 6 months to 12 years (myositis), immediate to over 20 years (PID), and 6 months to 15 years (sarcoidosis). We identified four themes that described the experiences of participants with a rare disease as they sought a diagnosis for their condition: (1) normalising and/or misattributing symptoms; (2) particularising by clinicians; (3) asserting patients' self-knowledge; and (4) working together through the diagnosable moment.
CONCLUSIONS
CONCLUSIONS
Managing medical uncertainty in the time before diagnosis of a rare disease can be complicated by patients discounting their own symptoms and/or clinicians discounting the scale and impact of those symptoms. Persistence on the part of both clinician and patient is necessary to reach a diagnosis of a rare disease. Strategies such as recognising pattern failure and accommodating self-labelling are key to diagnosis.
Identifiants
pubmed: 39143641
doi: 10.1186/s13023-024-03319-2
pii: 10.1186/s13023-024-03319-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
297Subventions
Organisme : Department of Health and Aged Care, Australian Government
ID : 4-G60XELC.
Informations de copyright
© 2024. The Author(s).
Références
Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77–8.
pubmed: 32020066
pmcid: 7771654
doi: 10.1038/d41573-019-00180-y
Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165–73.
pubmed: 31527858
doi: 10.1038/s41431-019-0508-0
Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet. 2008;371(9629):2039–41.
pubmed: 18555915
doi: 10.1016/S0140-6736(08)60872-7
Marwaha S, Knowles JW, Ashley EA. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome. Genome Med. 2022;14(1):23.
pubmed: 35220969
pmcid: 8883622
doi: 10.1186/s13073-022-01026-w
Priolo M, Tartaglia M. The right to ask, the need to answer - when patients Meet Research: how to cope with Time. Int J Environ Res Public Health. 2023;20(5):4573.
pubmed: 36901584
pmcid: 10002068
doi: 10.3390/ijerph20054573
Evans WR, Rafi I. Rare diseases in general practice: recognising the zebras among the horses. Br J Gen Pract. 2016;66(652):550–1.
pubmed: 27789486
pmcid: 5072891
doi: 10.3399/bjgp16X687625
Llubes-Arrià L, Sanromà-Ortíz M, Torné-Ruiz A, Carillo-Álvarez E, García-Expósito J, Roca J. Emotional experience of the diagnostic process of a rare disease and the perception of support systems: a scoping review. J Clin Nurs. 2022;31(1–2):20–31.
pubmed: 34137096
doi: 10.1111/jocn.15922
Dong D, Chung RY-N, Chan RHW, Gong S, Xu RH. Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China. Orphanet J Rare Dis. 2020;15(1):307.
pubmed: 33115515
pmcid: 7594300
doi: 10.1186/s13023-020-01587-2
Amaya-Uribe L, Rojas M, Azizi G, Anaya JM, Gershwin ME. Primary immunodeficiency and autoimmunity: a comprehensive review. J Autoimmun. 2019;99:52–72.
pubmed: 30795880
doi: 10.1016/j.jaut.2019.01.011
Namsrai T, Parkinson A, Chalmers A, Lowe C, Cook M, Phillips C, et al. Diagnostic delay of myositis: an integrated systematic review. Orphanet J Rare Dis. 2022;17(1):420.
pubmed: 36411487
pmcid: 9677896
doi: 10.1186/s13023-022-02570-9
Janssen LMA, van den Akker K, Boussihmad MA, de Vries E. Which triggers could support timely identification of primary antibody deficiency? A qualitative study using the patient perspective. Orphanet J Rare Dis. 2021;16(1):289.
pubmed: 34187500
pmcid: 8243743
doi: 10.1186/s13023-021-01918-x
Namsrai T, Phillips C, Parkinson A, Gregory D, Kelly E, Cook M et al. Diagnostic delay of sarcoidosis: an integrated systematic review. (under Review). 2024.
Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021;7(1):86.
pubmed: 34857798
doi: 10.1038/s41572-021-00321-x
Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64.
pubmed: 31953710
pmcid: 7082301
doi: 10.1007/s10875-019-00737-x
Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–507.
pubmed: 35748970
pmcid: 9244088
doi: 10.1007/s10875-022-01289-3
Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27(5):517–24.
pubmed: 17588141
doi: 10.1007/s10875-007-9105-z
European Society for Immune Deficiencies. ESID Registry Network Reporting Tool. ESID Registry [Internet]. 2023 30 January 2024 [cited 2024 30 January]. https://cci-reporting.uniklinik-freiburg.de/#/
Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011;31(6):968–76.
pubmed: 21956496
doi: 10.1007/s10875-011-9594-7
Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497–502.
pubmed: 17577648
doi: 10.1007/s10875-007-9103-1
Anderson JT, Cowan J, Condino-Neto A, Levy D, Prusty S. Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden. Clin Immunol. 2022;236:108931.
pubmed: 35063670
doi: 10.1016/j.clim.2022.108931
Shillitoe B, Bangs C, Guzman D, Gennery AR, Longhurst HJ, Slatter M, et al. The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clin Exp Immunol. 2018;192(3):284–91.
pubmed: 29878323
pmcid: 5980391
doi: 10.1111/cei.13125
Slade CA, Bosco JJ, Binh Giang T, Kruse E, Stirling RG, Cameron PU, et al. Delayed diagnosis and complications of predominantly antibody deficiencies in a cohort of Australian adults. Front Immunol. 2018;9:694.
pubmed: 29867917
pmcid: 5960671
doi: 10.3389/fimmu.2018.00694
Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S et al. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells. 2021;10(4).
Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26(5):527–34.
pubmed: 32701677
pmcid: 7755458
doi: 10.1097/MCP.0000000000000715
Rybicki BA, Major M, Popovich J Jr., Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234–41.
pubmed: 9012596
doi: 10.1093/oxfordjournals.aje.a009096
Brashers DE. Communication and uncertainty management. J Communication. 2001;51:477–97.
doi: 10.1111/j.1460-2466.2001.tb02892.x
Meyer AND, Giardina TD, Khawaja L, Singh H. Patient and clinician experiences of uncertainty in the diagnostic process: current understanding and future directions. Patient Educ Couns. 2021;104(11):2606–15.
pubmed: 34312032
doi: 10.1016/j.pec.2021.07.028
Scott IA, Doust JA, Keijzers G, Wallis KA. Coping with uncertainty in clinical practice: a narrative review. Med J Aust. 2023;218(9):418–25.
pubmed: 37087692
doi: 10.5694/mja2.51925
Ghosh AK, Joshi S. Tools to manage medical uncertainty. Diabetes Metabolic Syndrome: Clin Res Reviews. 2020;14(5):1529–33.
doi: 10.1016/j.dsx.2020.07.055
Helou MA, DiazGranados D, Ryan MS, Cyrus JW. Uncertainty in decision making in Medicine: a scoping review and thematic analysis of conceptual models. Acad Med. 2020;95(1):157–65.
pubmed: 31348062
pmcid: 6925325
doi: 10.1097/ACM.0000000000002902
Bylund CL, Peterson EB, Cameron KA. A practitioner’s guide to interpersonal communication theory: an overview and exploration of selected theories. Patient Educ Couns. 2012;87(3):261–7.
pubmed: 22112396
doi: 10.1016/j.pec.2011.10.006
Smith JA, Shinebourne P. Interpretative phenomenological analysis. APA handbook of research methods in psychology, Vol 2: Research designs: Quantitative, qualitative, neuropsychological, and biological. APA handbooks in psychology
Larkin M, Flowers P, Smith JA. Interpretative phenomenological analysis: theory, method and research. Interpretative Phenomenological Anal. 2021:1–100.
Biggerstaff D, Thompson AR. Interpretative Phenomenological Analysis (IPA): a qualitative methodology of choice in Healthcare Research. Qualitative Res Psychol. 2008;5(3):214–24.
doi: 10.1080/14780880802314304
George P, Alison R, Joanna S. Interpretive phenomenological analysis applied to healthcare research. Evid Based Nurs. 2019;22(1):7.
doi: 10.1136/ebnurs-2018-103017
QSR International. Nvivo qualitative data analysis software(Version 12) 2020. https://www.qsrinternationalcom/nvivo-qualitative-data-analysis-software/home
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.
pubmed: 17872937
doi: 10.1093/intqhc/mzm042
Lincoln YS, Guba EG. Naturalistic inquiry. Beverly Hills, Calif: Sage; 1985.
doi: 10.1016/0147-1767(85)90062-8
Budych K, Helms TM, Schultz C. How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient–physician interaction. Health Policy. 2012;105(2):154–64.
pubmed: 22464590
doi: 10.1016/j.healthpol.2012.02.018
Taruscio D, Salvatore M, Lumaka A, Carta C, Cellai LL, Ferrari G, et al. Undiagnosed diseases: needs and opportunities in 20 countries participating in the undiagnosed diseases Network International. Front Public Health. 2023;11:1079601.
pubmed: 36935719
pmcid: 10017550
doi: 10.3389/fpubh.2023.1079601
Cooke G, Valenti L, Glasziou P, Britt H. Common general practice presentations and publication frequency. Aus Fam Physician. 2013;42(1/2):65–8.
Australian Bureau of Statistics. Asthma [Internet], Canberra ABS. 2020-21 Canberra2023 [ https://www.abs.gov.au/statistics/health/health-conditions-and-risks/asthma/latest-release
Nijrolder I, van der Windt D, de Vries H, van der Horst H. Diagnoses during follow-up of patients presenting with fatigue in primary care. CMAJ. 2009;181(10):683–7.
pubmed: 19858240
pmcid: 2774363
doi: 10.1503/cmaj.090647
Stone L. Reframing chaos: a qualitative study of GPs managing patients with medically unexplained symptoms. Aus Fam Physician. 2013;42(7):1–7.
Bösner S, Abushi J, Feufel M, Donner-Banzhoff N. Diagnostic strategies in general practice and the emergency department: a comparative qualitative analysis. BMJ open. 2019;9(5):e026222–e.
pubmed: 31154305
pmcid: 6549708
doi: 10.1136/bmjopen-2018-026222
Coia P, Morley S. Medical reassurance and patients’ responses. J Psychosom Res. 1998;45(5):377–86.
pubmed: 9835230
Pincus T, Holt N, Vogel S, Underwood M, Savage R, Walsh DA, et al. Cognitive and affective reassurance and patient outcomes in primary care: a systematic review. Pain. 2013;154(11):2407–16.
pubmed: 23872104
doi: 10.1016/j.pain.2013.07.019
Levine DM, Mehrotra A. Assessment of diagnosis and triage in validated case vignettes among nonphysicians before and after internet search. JAMA Netw open. 2021;4(3):e213287–e.
pubmed: 33779741
pmcid: 8008286
doi: 10.1001/jamanetworkopen.2021.3287